ClinicalTrials.gov
public full text
Public Domain
A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy
This study will evaluate the efficacy, safety, pharmacokinetics(PK) ,pharmacodynamics（PD）and anti-drug antibodies（ADA） of MIL62 compared with cyclosporine in participants with primary membranous nephropathy (pMN).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy#874838
- Animal models of idiopathic membranous nephropathy: Recent advances and future perspectives.#396003
- Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy#897520
- Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy#892071
- The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia#1072825
Record · ID 912746
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive